Aultman Health Foundation

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Aultman Health Foundation sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 9 completed later-stage tilt top decile by trial count

Aultman Health Foundation: 12 sponsored US clinical trials, none currently recruiting.

Aultman Health Foundation sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 6 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ileus, with 1 trials.

Top-decile sponsor footprint

Aultman Health Foundation ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 27/100

9 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED Phase 4

Improving Post-Operative Pain and Recovery in Gynecologic Surgery

NCT04175509
TERMINATED Phase 2

Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma

NCT03787303
COMPLETED NA

Effects of a Metronome on Functional Outcomes in Aquatic Therapy

NCT03801772
COMPLETED Phase 4

Vapocoolant Spray Used Prior to Intravenous (IV) Insertions

NCT03054740
COMPLETED NA

The Impact of a mHealth Application on Outpatient Physical Therapy HEP Adherence and Outcomes: A RCT

NCT03035682
COMPLETED Phase 4

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

NCT02832115
TERMINATED Phase 3

Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.

NCT02620384
COMPLETED Phase 4

Efficacy of IV Acetaminophen for Pain Management

NCT02028715
COMPLETED NA

Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon

NCT01139801
COMPLETED NA

Prevention of Ileus After Gynecologic Surgery Using Chewing Gum

NCT00831246
COMPLETED Phase 4

Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy

NCT00550290
TERMINATED Phase 2

Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

NCT00315211

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1
Phase 4 5

Therapeutic Areas

Ileus 1
Orthopedic Disorder 1
Postoperative Pain 1
Musculoskeletal Injury 1

How the Aultman Health Foundation archive is shaped

12 indexed studies, none listed as recruiting (0% open); 9 completed (75%).

Phase mix: 6 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Ileus (1 trial), 3 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Aultman Health Foundation: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Aultman Health Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share Aultman Health FoundationAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.Angiodynamics10xBio22nd Century Group23andMe3-C Institute for Social Development
Aultman Health Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Aultman Health Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Aultman Health Foundation page

12 registered trials is a research-attention snapshot, not an endorsement of Aultman Health Foundation or any single study.

  • None of Aultman Health Foundation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Ileus is the condition Aultman Health Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ileus trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Aultman Health Foundation pipeline card: 12 registered trials from official public datasets.Report a data error.